Právní předpis byl sestaven k datu 01.07.2024.
Zobrazené znění právního předpisu je účinné od 01.07.2024 do 31.12.2024.
Příloha č. 1 - Seznam č. 1 omamných látek
Příloha č. 2 - Seznam č. 2 omamných látek
Příloha č. 3 - Seznam č. 3 omamných látek
Příloha č. 4 - Seznam č. 4 psychotropních látek
Příloha č. 5 - Seznam č. 5 psychotropních látek
Příloha č. 6 - Seznam č. 6 psychotropních látek
Příloha č. 7 - Seznam č. 7 psychotropních látek
Příloha č. 8 - Seznam č. 8 vybraných přípravků
č. 46/2017 Sb. - Čl. II
č. 30/2018 Sb. - Čl. II
č. 242/2018 Sb. - Čl. II
č. 194/2021 Sb. - Čl. II
č. 159/2022 Sb. - Čl. II
č. 228/2023 Sb. - Čl. II
č. 52/2024 Sb. - Čl. II
č. 176/2024 Sb. - Čl. II
463
NAŘÍZENÍ XXXXX
xx dne 18. prosince 2013
o xxxxxxxxx xxxxxxxxxx xxxxx
Xxxxx xxxxxxxx podle §44c xxxx. 1 zákona x. 167/1998 Xx., x xxxxxxxxxx xxxxxxx x x změně xxxxxxxxx xxxxxxx zákonů, xx xxxxx xxxxxx x. 273/2013 Sb.:
§1
Xxxx xxxxxxxx xxxxxxx
x) x příloze č. 1 x xxxxxx nařízení xxxxxx
1. xxxxxxxx látek xxxxxxxxxx xx Xxxxxxx I xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx1) x
2. xxxxxxx omamných xxxxx, x xxxxx xx z důvodu xxxxxxx xxxxxx xxxxxxxxxx xxxxx proto, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx zacházení xxx xx základě xxxxxxxx x zacházení, xxxx xx z tohoto xxxxxx xxxxx xxxxxxxxxx, xxx xxxxxx přípravky xxxxxxxxxx tyto xxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx pouze xx xxxxxx xxxx xxxxxxx xxxxxxxx modrým xxxxxx xxxxxxxxxx z xxxxxx dolního rohu xx xxxxxxx horního xxxx,
(xxxx xxx "xxxxxx x. 1 xxxxxxxx xxxxx"),
x) v příloze č. 2 x xxxxxx nařízení xxxxxx
1. omamných xxxxx xxxxxxxxxx xx Xxxxxxx XX podle Xxxxxxxx xxxxxx x omamných xxxxxxx x
2. xxxxxxx xxxxxxxx xxxxx, x xxxxx je x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxxx xxxxx xxxx xxxxxxxx x xxxxxxx xx recept xxxx žádanku bez xxxxxxxx xxxxxx xxxxxx,
(xxxx xxx "seznam č. 2 xxxxxxxx látek"),
c) x příloze č. 3 x xxxxxx xxxxxxxx xxxxxx
1. xxxxxxxx xxxxx zařazených xx Xxxxxxx XX xxxxx Xxxxxxxx úmluvy x omamných xxxxxxx x
2. xxxxxxx omamných xxxxx, u xxxxx xx x xxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx nebo xxxxxxx xxxxxxxx xxxxxx, nutné xxxxxxxxxx, xxx látky x přípravky xxxxxxxxxx xxxx xxxxxx xxxxx xxxx xxxxxxxxx xxxxx x xxxxxxxx xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx xxxxxxxxxxxxx účelům xxxxxxxxx v povolení x zacházení,
(dále xxx "xxxxxx č. 3 xxxxxxxx látek"),
d) x příloze č. 4 x tomuto xxxxxxxx xxxxxx
1. psychotropních xxxxx xxxxxxxxxx xx Xxxxxxx X podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx2) x
2. dalších xxxxxxxxxxxxxx xxxxx, x xxxxx xx x xxxxxx rozsahu xxxxxx xxxxxxxxxx xxxxx xxxxx, xx xxxxxxxxxxxxx xxxx xxxxxxx ohrožují zdraví, xxxxx xxxxxxxxxx, aby xxxxx x xxxxxxxxx xxxxxxxxxx tyto xxxxxxxxxxxx xxxxx xxxx xxxxxxxxx xxxxx x omezeným xxxxxxxxx, xxxxxxxx x xxxxx xxxxxxxx terapeutickým xxxxxx vymezeným v xxxxxxxx x zacházení,
(dále xxx "xxxxxx x. 4 psychotropních látek"),
e) x příloze č. 5 x xxxxxx nařízení xxxxxx
1. xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Seznamu II xxxxx Xxxxxx x xxxxxxxxxxxxxx xxxxxxx a
2. xxxxxxx psychotropních látek, x xxxxx je x důvodu xxxxxxx xxxxxx xxxxxxxxxx anebo xxxxx, že xxxxxxxxxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxxxxx xxxxxxx xxxxxxxxx jen xx xxxxxxx xxxxxxxx k xxxxxxxxx, nebo xx x xxxxxx důvodu xxxxx xxxxxxxxxx, aby xxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxxxxx látky xxxx vydávány v xxxxxxx pouze na xxxxxx xxxx xxxxxxx xxxxxxxx xxxxxx pruhem xxxxxxxxxx x levého xxxxxxx rohu do xxxxxxx xxxxxxx rohu,
(dále xxx "xxxxxx č. 5 xxxxxxxxxxxxxx látek"),
f) x příloze č. 6 x xxxxxx nařízení xxxxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xx Xxxxxxx III xxxxx Xxxxxx o xxxxxxxxxxxxxx xxxxxxx,
x) x příloze č. 7 x tomuto xxxxxxxx seznam
1. xxxxxxxxxxxxxx xxxxx zařazených do Xxxxxxx IV podle Xxxxxx x xxxxxxxxxxxxxx xxxxxxx x
2. xxxxxxx xxxxxxxxxxxxxx xxxxx, x xxxxx je x xxxxxx xxxxxxx jejich xxxxxxxxxx xxxxx xxxxx, xx bezprostředně xxxx xxxxxxx xxxxxxxx xxxxxx, xxxxx xxxxxxxxxx, xxx xxxxxx xxxxxxxxx obsahující xxxx xxxxx xxxx xxxxxxxx v xxxxxxx xx recept nebo xxxxxxx xxx označení xxxxxx pruhem,
(dále xxx "xxxxxx x. 7 xxxxxxxxxxxxxx xxxxx"), x
x) x příloze č. 8 k xxxxxx nařízení seznam xxxxxxxxx xxxxxxxxxx xx Xxxxxxx III xxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx,
(xxxx jen "xxxxxx x. 8 xxxxxxxxx xxxxxxxxx").
§2
(1) Xxxx xxxxxxxx xxxx oznámeno v xxxxxxx se směrnicí Xxxxxxxxxx parlamentu a Xxxx 98/34/ES xx xxx 22. xxxxxx 1998 x xxxxxxx xxx xxxxxxxxxxx informací x xxxxxxx xxxxx x xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx informační xxxxxxxxxxx, x xxxxxxx xxxxx.
(2) Xxxx nařízení xxxxxxxxxxx xxxxxxxxx předpisy Evropské xxxx xxxxxxxx xx xxxxxxxxxx látek3).
§3
Toto xxxxxxxx nabývá xxxxxxxxx xxxx 1. xxxxx 2014.
Xxxxxxx x. 1 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 1 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(5X,6X,7X)-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-4,5-xxxxx-6,14-xxxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxx-xxxx-xxxxxxxxxxxxxx |
(XX)-X-[1-(2-xxxxx-2-xxxxxxxxxxx)-4-xxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(3XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxx-xxxxxxxxxxxxxx |
X-{1-[(1XX)-2-xxxxx-1-xxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxx |
X-{1-[(1XX)-1-xxxxxx-2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxx xxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
X-{1-[2-(4-xxxxx-5-xxx-4,5-xxxxxxx-1X-xxxxxxxx-1-xx)xxxxx]-4-(xxxxxxxxxxxxx)xxxxxxxxx-4-xx}-X-xxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxxx |
3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-(4-xxxxxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-[2-(xxxxxxxxx)xxxxx]-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx-xxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxx-xxxxxxxxxxxxxxxxxxxxx |
X-{1-[(2XX)-2-xxxxxxxxxxxxxxx]-3-xxxxxxxxxxxxxxx-4-xx}xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3XX,4XX)-3-xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxxxx |
(3X,6X)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(3XX,4XX)-4-xxxxx-1,3-xxxxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
|
|
Xxxxxxxxxx |
2,2-xxxxxxx-4-[4-(2-xxx-3-xxxxxxxxx-2,3-xxxxxxx-1X-xxxxxxxxxxxx-1-xx)xxxxxxxxxx]xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
1-[(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx]xxxxxxxxxx |
|
|
Xxxxxxxxxx |
X-[2-(X-xxxxxxxx-X-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxx |
3-(xxxxxxxxxxxx)-1,1-xx(2-xxxxxxx)xxx-1-xx |
|
|
Xxxxxxxxx |
1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
xxxxx-1-(3,3-xxxxxxx-3-xxxxxxxxxx)-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
(5X,6X,7X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxxxx-3,6α-xxxx |
|
|
Xxxxxxxxxxx |
[2-(xxxxxxxxxxxxx)xxxxx]-2-xxxxxx-2,2-xxxxxxx-xxxxxx |
|
|
Xxxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
X,X,1-xxxxxxxxx-3,3-xx(2-xxxxxxx)xxxxxxxxx |
|
|
Xxxxxxxxxx-xxxxxxx |
xxxxx-2,2-xxxxxxx-4-xxxxxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
(6XX)-4,4-xxxxxxx-6-xxxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxxx |
(6X)-3,4-xxxxxxxxx-17-xxxxxxxxxxxxxx-6β,14-xxxx |
|
|
Xxxxxxx |
xxxxxxxx (x.X.2X,3X5X)3-xxxxxxx-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxxx, její xxxxxx x xxxxxxxx, x xxxxxxx je xxxxx xxxxxx ekgonin x kokain |
|
|
Ethylmethylthiambuten |
N-ethyl-N,1-dimethyl-3,3-bis(2-thienyl)-2-propenylamin |
|
|
Etonitazen |
1-[2-(diethylamino)ethyl]-2-(4-ethoxybenzyl)-5-nitro-1H-benzimidazol |
|
|
Etoxeridin |
ethyl-4-fenyl-1-[2-(2-hydroxyethoxy)ethyl]piperidin-4-karboxylát |
|
|
Extrakt x xxxxxx pro xxxxxxx xxxxxxx |
Xxxxxxx x konopí xxxxxxxx x xxxxxxxx xxxxxxxx přípravků xx xxxxxxxxxxxxxxxx xxxxxxx tetrahydrokanabinolu |
|
|
Fenadoxon |
4,4-difenyl-6-morfolinoheptan-3-on |
|
|
Fenampromid |
N-(1-methyl-2-piperidinoethyl)propananilid |
|
|
Fenazocin |
(2RS,6R,11R)-3-fenethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol |
|
|
Fenomorfan |
17-fenethylmorfinan-3-ol |
|
|
Fenoperidin |
ethyl-4-fenyl-1-(3-fenylpropyl)-3-hydroxypiperidin-4-karboxylát |
|
|
Fentanyl |
N-(1-fenethylpiperidin-4-yl)-N-fenylpropanamid |
|
|
Furethidin |
ethyl-4-fenyl-1-[2-(furfuryloxy)ethyl]piperidin-4-karboxylát |
|
|
Hydrokodon |
4,5α-epoxy-3-methoxy-17-methylmorfinan-6-on |
|
|
Hydromorfinol |
4,5α-epoxy-17-methylmorfinan-3,6α,14-triol |
|
|
Hydromorfon |
4,5α-epoxy-3-hydroxy-17-methylmorfinan-6-on |
|
|
Hydroxypethidin |
ethyl-4-(3-hydroxyfenyl)-1-methylpiperidin-4-carboxylát |
|
|
Isomethadon |
6-(dimethylamino)-4,4-difenyl-5-methylhexan-3-on |
|
|
Karfentanil |
methyl-1-fenethyl-4-(N-fenylpropanamido)piperidin-4-karboxylát |
|
|
Klonitazen |
2-(4-chlorbenzyl)-1-[2-(diethylamino)ethyl]-5-nitro-1H-benzimidazol |
|
|
Kodoxim |
kyselina 2-{[X-(4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xxxxxx)xxxxx]xxx}xxxxxx |
|
|
Xxxx - xxxx |
Xxxxxx xxxx |
|
|
Xxxxxx |
(1X,2X,3X,5X)-3-(xxxxxxxxxx)-8-xxxxxx-8-xxxxxxxxxx[3.2.1]xxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxx z makoviny |
Poloprodukt x xxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx xxxxxxxx |
|
|
Xxxxxx extrakt x xxxxxxxx |
X xxxxxxxx xxxxx xxxxxx extrakt a xxxxxxxx, xxxxx xxxxxxxx 1 % xxxxx xx skupiny xxxxxxxxxxxxxxxxxxxx x xxxxxxx xxxxxxxx xxxxxxxxxxx podle xxxxxx x obecné xxxxxxxxxxx xxxxxxx |
|
|
Xxxxxx xxx xxxxxxx xxxxxxx |
||
|
Xxxxxxxxxxxxxxxxx |
1-xxxxx-2-[9X,13X,14X)3-xxxxxxxxxxxxxxx-17-xx]xxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-3-xxxxxxx-17-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxx dextromethorfan [(+)-3-methoxy-17-methylmorfinan] xx xxxxx xx xxxxxxx xxxxxxxx xxxxx xxxxxxxxx x této xxxxxxx |
|
Xxxxxxxxxxx |
(3X)-2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxx-1-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
Xxxxxxxxxx |
(9X,13X,14X)-17-xxxxxxxxxxxxxx-3-xx |
Xxxxxxxxxxxxxx xxxxxxxxxxxx [(+)-3-hydroxy-17-methylmorfinan] xx xxxxx ze xxxxxxx omamných xxxxx xxxxxxxxx v xxxx xxxxxxx |
|
Xxxxxxxxx |
(2X,6X,11X)-3,6,11-xxxxxxxxx-1,2,3,4,5,6-xxxxxxxxx-2,6-xxxxxxxxx-3-xxxxxxxxx-8-xx |
|
|
Xxxxxxxx |
(6XX)-6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxx, meziprodukt |
4-(dimethylamino)-2,2-difenylpentannitril |
|
|
Methyldesorfin |
4,5α-epoxy-6,17-dimethylmorfin-6-en-3-ol |
|
|
Methyldihydromorfín |
4,5-epoxy-6,17-dimethylmorfínan-3,6-diol |
|
|
Metopon |
4,5-epoxy-3-hydroxy-5,17-dimethylmorfinan-6-on |
|
|
Moramid, xxxxxxxxxxx |
2,2-xxxxxxx-3-xxxxxx-4-xxxxxxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
X-(1-xxxxxxxx-3-xxxxxxxxxxxxxxx-4-xx)xxxxxxxxxxxx |
3-Xxxxx xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxx |
X-{(3XX)-3-xxxxxx-1-[2-(2-xxxxxxx)xxxxx]xxxxxxxxx-4-xx}xxxxxxxxxxxx |
3-xxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx |
xxxxxxxx xxxxxxxxxx rostlina konopí xxx xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-4-xxxxx-1-(2-xxxxxxxxxxxxxx)xxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxx xxxxxxxxxxx |
4,5α-xxxxx-3,6α-xxxxxxxxx-17,17-xxxxxxxxxxxxxx-7-xx-17-xxx-xxxxxx |
x xxxx xxxxxxxx xxxxxxx xx čtyřvazným dusíkem xxxxxx derivátů morfin-N-oxidu |
|
Xxxxxx-X-xxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-17-xxxx |
|
|
Xxxxxxxxxxxxxxx |
4-xxxxx-1-xxxxxxxxxxxxxxx-4-xx-xxxxxxxxx |
XXXX |
|
Xxxxxxx |
3-(xxxxxxxxx)-4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-6-xx-xxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
4,5α-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6α-xxxx-xxxxxxxxxxx |
|
|
Xxxxxxxxxxxxxx |
4,4-xxxxxxx-6-(xxxxxxxxxxx)xxxxxx-3-xx-xxxxxx |
|
|
Xxxxxxxxxxxxx |
(9X,13X,14X)-xxxxxxxx-3-xx |
|
|
Xxxxxxxxxxx |
6-(xxxxxxxxxxxxx)-4,4-xxxxxxxxxxxx-3-xx |
|
|
Xxxxxxxxx |
4,5α-xxxxxxxxxxx-7-xx-3,6α-xxxx |
|
|
Xxxxxxxxxx |
4,4-xxxxxxx-6-xxxxxxxxxxxxxxx-3-xx |
|
|
Xxxxx |
Xxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, jejichž xxxxxx xxxxxx xx vyšší xxx X4 xxxx XX2 |
|
|
Xxxxxxxx |
4,5α-xxxxx-6-xxxxxxx-17-xxxxxxxxxxxxx-6,8(14)-xxxx-3-xx |
|
|
Xxxxxxxx |
(5X)-4,5-xxxxx-14-xxxxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxx |
(5X)-4,5-xxxxx-3,14-xxxxxxxxx-17-xxxxxxxxxxxxxx-6-xx |
|
|
Xxxxxxxxxxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx-4-xx)-4'-xxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
xxxxx-1-xxxxxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
XXXXX |
|
Xxxxxxxx |
xxxxx-4-xxxxx-1-xxxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, xxxxxxxxxxx A |
4-fenyl-1-methylpiperidin-4-karbonitril |
|
|
Pethidin, xxxxxxxxxxx X |
xxxxx-4-xxxxxxxxxxxxxx-4-xxxxxxxxxx |
|
|
Xxxxxxxx, meziprodukt X |
xxxxxxxx 4-fenyl-1-methylpiperidin-4-karboxylová |
|
|
Piminodin |
ethyl-1-(3-anilinopropyl)-4-fenylpiperidin-4-karboxylát |
|
|
Piritramid |
1'-(3,3-difenyl-3-kyanpropyl)-4'-ureido-1,4'-bipiperidin |
|
|
Proheptazin |
4-fenyl-1,3-dimethylazepan-4-yl-propanoát |
|
|
Properidin |
isopropyl-4-fenyl-1-methylpiperidin-4-karboxylát |
|
|
Racemethorfan |
(9RS,13RS,14RS)-3-methoxy-17-methylmorfinan |
|
|
Racemoramid |
(3RS)-2,2-difenyl-3-methyl-4-morfolino-1-(pyrrolidin-1-yl)butan-1-on |
|
|
Racemorfan |
(9RS,13RS,14RS)-17-methylmorfinan-3-ol |
|
|
Remifentanil |
methyl-3-[4-(N-acetonylanilino)-4-(methoxykarbonyl)]piperidino]propanoát |
|
|
Sufentanil |
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tapentadol |
3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]fenol |
|
|
Thebain |
4,5α-epoxy-3,6-dimethoxy-17-methylmorfína-6,8-dien |
|
|
Thebakon |
(5R)-4,5-epoxy-3-methoxy-17-methylmorfin-6-en-6-yl-acetát |
|
|
Thiofentanyl |
N-{1-[2-(2-thienyl)ethyl]piperidin-4-yl}propananilid |
|
|
Tilidin |
ethyl-(1RS,2RS)-2-(dimethylamino)-1-fenylcyklohex-3-en-1-karboxylát |
|
|
Trimeperidin |
(RS)-4-fenyl-4-(1,2,5-trimethylpiperidin-4-yl)propanoát |
Včetně xxxxxxx xxxxxxxx látek uvedených x xxxxx seznamu, xxxx xxxxxx a xxxxxx xxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx x xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxx, xxxxxx xxxx izomerů, xxxxxx x éterů xx všech případech, xxx xxxx soli xxxxx xxxxxxxxx.
Příloha x. 2 x nařízení vlády x. 463/2013 Xx.
Xxxxxx x. 2 xxxxxxxx xxxxx
|
Xxxxxxxxxxx nechráněný název (XXX) x xxxxxx xxxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxx |
|
|
Xxxxxxxxxxxxxxxx |
(1X,2X)-1-xxxxxx-3-(xxxxxxxxxxxxx)-1-xxxxxxxxxxxx-xxxxxxxxx |
|
|
Xxxxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
4,5α-xxxxx-17-xxxxxx-3-(2-xxxxxxxxxxxxxxx)xxxxxx-7-xx-6α-xx |
|
|
Xxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxxxx-6α-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxx-17-xxxxxxxxxxxx--7-xx-6-xx-xxxxxxxxx |
|
|
Xxxxxxxxx |
4,5α-xxxxx-3-xxxxxxxxxxxxx-7-xx-6α-xx |
|
|
Xxxxxxxx |
X-[(1XX)-1-xxxxxx-2-xxxxxxxxxxxxxxx]-X-(2-xxxxxxx)xxxxxxxxxx |
Xxxxxx xxxxxxx omamných xxxxx uvedených x xxxxx seznamu, dále xxxx omamných xxxxx xxxxxxxxx x xxxxx xxxxxxx, včetně xxxx xxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxx xxxx xxxxx xxxxxxxxx.
Xxxxxxx x. 3 x xxxxxxxx xxxxx x. 463/2013 Sb.
Seznam x. 3 xxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx |
Další xxxxxxxxxxx nechráněný xxxxx xxxx xxxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxx |
XXX 73750; benzylacetylfentanyl |
N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid |
|
|
Acetylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid |
||
|
Acryloylfentanyl |
Acrylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid |
|
|
AH-7921 |
3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid |
||
|
AP-237 |
bucinnazin; 1-X-xxxxxxx-4-xxxxxxxxxxxxxxxxxx; |
1-[4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xxxxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXX-X; benzodioxole-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2H-1,3-benzodioxol-5-karboxamid |
|
|
Benzoylbenzylfentanyl |
N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid |
||
|
Benzoylfentanyl |
fenylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid |
|
|
Benzylfentanyl |
Benzyl-F; R4129 |
N-íeny\-N-[1-(fenylmethyl)piperidin-4-yl]propanamid |
|
|
Benzylfurany1fentany 1 |
Xxxxxx FuF |
N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid |
|
|
Bromadolin |
U4793e;U47931E |
4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid |
|
| Brorfin | Brorphine | 3-{1-[1-(4-bromfenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-on | |
|
Butonitazen |
2-[(4-butoxyfenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazol-1-ethanamin |
||
|
4-Chlorisobutyrfentanyl |
4-Cl-iBF |
N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
|
Cyklopentylfentanyl |
Cyclopentyl-F; CP-F |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid |
|
|
Cyklopropylfentanyl |
N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid |
||
|
Desomorfin |
4,5α-epoxy-17-methylmorfinan-3-ol |
||
|
Despropionyl-2-fluor xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxxxxx-4-xxxxx xxxxxxxx |
X-(4-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
|
Xxxxxx |
xxxxxxxxxxxxxx |
2-[2-[(4-xxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]-X,X-xxxxxxxxxxxxxxxx |
|
| Xxxxxxxxxxxx | 2-[(4-xxxxxxxxxxx) xxxxxx-5-xxxxx-1-(2-xxxxxxxxxx-1-xxxxxxx)-1X-xxxx-xxxxxxxx | ||
|
Xxxxxxx |
(5X,6X,7X, 14X)-4,5-xxxxx-7-[(2X)-2-xxxxxxxxxxxxx-2-xx]-6-xxxxxxx-17-xxxxxx-6,14-xxxxxxxxxxxxxx-3-xx |
||
|
Xxxxxxxx xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-3-xxxxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxx |
X,X-xxxxxxx-2-{2-[(4-xxxxxxxxxx)xxxxxx]-5-xxxxx-1X-xxxxxxxxxxxx-1-xx}xxxxxxxxx |
||
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
|
4-Xxxxx-xxxxxxxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxx-4-xx)-xxxxxxxxxxxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
|
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
|
4-Xxxxxxxxxxxxxxxxxxxx |
xxxx-xxxxxxxxxxxxxxxxxxxx; 4F-furanyl xxxxxxxx |
X-(4-xxxxxxxxxx)-X-(1-xxxxxxxxxxxxxxxxx-4-xx)xxxxx-2-xxxxxxxxxx |
|
|
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxxxxxxxxx |
xxxxx-xxxxxxxxxxxxxxxxxx-xxxxxxxx |
X-(3-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
XX-X; 2-xxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx |
|
|
(xxx)Xxxxxxx-X-xxxxxxxx N-benzyl xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
|
Xxxxxx |
(5X,6X)-4,5-xxxxx-17-xxxxxxxxxxxx-7-xx-3,6-xxxx-xxxxxxxx |
||
|
4-xxxxxxxxxxxxxxxxxxxx |
4-XX-XX; para-hydroxybutyrylfentanyl |
N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid |
|
|
Isopropyl-U-47700 |
3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid |
||
|
Isotonitazen |
N,N-diethyl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1H-benzimidazol-1-ethanamin |
||
|
Ketobemidon |
1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on |
||
|
Konopí |
S xxxxxxxx xxxxxx xxx xxxxxxx xxxxxxx xxxxxxx v xxxxxxx č. 1 |
||
|
Xxxxxxxxxxxxxxxx |
(2X)-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxx-4-xx]-2-xxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
4-Xxxxxxxxxxxx xxxxxxxx |
4-XxX-XX |
X-(4-xxxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxxxxx |
x-xxxxxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-xxxxxxxx |
|
|
2-Xxxxxx-XX-237 |
2-xxxxxx-xxxxxxxxxx |
1-[2-xxxxxx-4-(3-xxxxxxxxx-2-xx-1-xx)xxxxxxxxx-1-xxxxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxx-X-47700 |
3,4-XXX-X-47700; |
N-(2-(dimethylamino)cyklohexyl)-N-methylbenzo[d][1,3]dioxol-5-karboxamid |
|
|
α-Methylfentanyl xxxxxxxxx xxxxxx |
XX; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxxxxxxxx |
β'-xxxxxxxxxxxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-xxxxxxxxx-4-xx]-3-xxxxxxxxx-2-xxxxxx |
|
|
Xxxxxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]xxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
|
Xxxxxxxxxxx |
X,X-xxxxxxx-2-[2-[(4-xxxxxxxxxxxx)xxxxxx]-5-xxxxxxxxxxxxxxxxx-1-xx]xxxxxxxxx |
||
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
|
X-xxxxxx X-47931X |
X-xxxxxxxxxxxxxxxx |
4-xxxx-X-(2-(xxxxxxxxxxxxx)xxxxxxxxxx)-X-xxxxxxxxxxxxxx |
|
|
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
xxxxxxxxxxxxx, XXX, 127X49 |
1-(4,4-xx(xxxxxxx-2-xx)xxx-3-xx-2-xx)xxxxxxxxx |
|
| Xxxxxxxxxxxx | X,X-xxxxxxx-5-xxxxx-2-[(4-xxxxxxxxxxxx)xxxxxx]-1-X-xxxxxxxxxxxx-1-xxxxxxxxx) | ||
|
Xxxxxxxxxx x xxxxxx |
|||
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX-xxxxxxxx; XXXX-X |
Ν-xxxxx-Ν-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-1-xxxxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxx fentanyl |
N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid |
|
|
U-47700 |
3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid |
||
|
U-48800 |
2-(2,4-dichlorfenyl)-N-(2-(dimethylamino)cyklohexyl)-N-methylacetamid |
||
|
U-49900 |
3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid |
||
|
U-50488 |
3,4-dichlor-N-methyl-N-[2-(1-pyrrolidinyl)cyklohexyl] xxxxxxxxxxxxxx |
||
|
X-51754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
XXX, XX |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxx; xxxxxxxx xxxxxxxxxx xxxxxx |
Xxxxxx xxxx xxxxxxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx případech, xxx xxxx soli xxxxx existovat.
Xxxxxxx č. 4 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 4 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) |
Xxxxx xxxxxxxxxxx nechráněný xxxxx xxxx další xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
1-(Xxxxxxxxxxxxxxxx)-2-[(4-xxxxxxxxxxx)xxxxxx]-X,X-xxxxxxx-1X-xxxxxxxxxxxx-5-xxxxxxxxxx |
|||
|
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
|
1-(2-(Xxxxxxxxxxx)xxxxxxxxx)xxxxxxxx |
XXXXX |
2-(xxxxxxxxxxx)-1-(xxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
|
1-Xxxxxxx |
1-xxxxxxxxx |
1-xxxxxxxx-1-xx-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
|
1x-XXX, 1X-XXX |
xxxxxxxxxxx xxxxxxxx 1-xxxxxxxxx lysergové; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx- -6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid |
||
|
2,3-Dimethylmetkathinon |
2,3-DMMC |
1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
2,3-Methylendioxymethkathinon |
2,3-MDMC |
1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on |
|
|
2,4,5-Trimethylmethkathinon |
2,4,5-TMMC |
||
|
2,4,6-Trimethoxyamfetamin |
TMA-6 |
1-(2,4,6-trimethoxyfenyl)propan-2-amin |
|
|
2,4-Dimethylethkathinon |
2,4-DMEC |
1-(2,4-dimethylfenyl)-2-(ethylamino)propan-1-on |
|
|
2,4-Dimethylmetkathinon |
2,4-DMMC |
1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on |
|
|
2',4'-Dimethyl-α-pyrrolidinpropiofenon |
2,4-DMPPP |
1-(2,4-dimethylfenyl)-2-pyrrolidin-1-yl-propan-1-on |
|
|
2,5-Dimethoxy-4-chloramfetamin |
DOC |
1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin |
|
|
2,5-Dimethoxy-4-jodamfetamin |
DOI |
1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin |
|
|
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
|
25I-NBF; 25X-XX2X; 2X-X-XXX, NBF-2C-I; Xxxxx-21 |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxx)xxxxxx]xxxxxxxxx |
||
|
25X-XXXX |
2-{[2-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxx |
2X-X-XXXX; Xxxxx-27 |
|
|
251-XXXXx |
2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx |
XXXXx-2X-X |
|
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
2X-X-XXX |
2X-X-XXX |
2-(4-xxxx-2,3,6,7-xxxxxxxxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxxxxx |
|
|
2X-X |
2X-X |
2,5-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxx |
XX-25 |
|
2X-X |
2X-X |
2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-2-xxxxxxxxxxx-1-(2-xxxxxxxxxx)xxxxxx-1-xx |
|
|
2-Xxxxxxxxxxxxxx |
2-XX |
1-(2-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
2-Xxxxxxxxxxxxxxxxxxxx |
2-Xx-2'-Xxx-XXX, |
2-(2-xxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxxxxxxxx |
|
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX; 2-fluoroethamphetamine |
N-ethyl-1-(2-fluorfenyl)propan-2-amin |
|
|
2-Fluorethkathinon |
2-FEC |
1-(2-fluorfenyl)-2-(ethylamino)propan-1-on |
|
|
2-Fluormethamfetamin |
2-FMA |
(RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin |
|
|
2-Fluormethkathinon |
2-FMC |
1-(2-fluorfenyl)-2-(methylamino)propan-1-on |
|
|
2F-QMPSB; SGT-13 |
8-chinolinyl-3-[(4,4-difluoφiperidin-1-yl)sulfonyl]-4-methylbenzoát |
||
|
2-Chloramfetamin |
2-CA |
1-(2-chlorfenyl)propan-2-amin |
|
|
2-Chlorethkathinon |
2-CEC |
1-(2-chlorfenyl)-2-(ethylamino)propan-1-on |
|
|
2-Chlormethamfetamin |
2-CMA |
1-(2-chlorfenyl)-N-methylpropan-2-amin |
|
|
2-Chlormethkathinon |
2-CMC |
1-(2-chlorfenyl)-2-(methylamino)propan-1-on |
|
|
2-Chlorpentedron |
2-CPD |
1-(2-chlorfenyl)-2-(methylamino)pentan-1-on |
|
|
2-MAPB |
1-(benzofuran-2-yl)-N-methylpropan-2-amin |
||
|
2-Methoxymethylon |
N-methyl-bk-MMDA-2 |
1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-on |
|
|
2-Methylamfetamin |
2-MA |
(2RS)-1-(2-methylfenyl)propan-2-amin |
|
|
2-Methylethkathinon |
2-MEC |
2-(ethylamino)-1-(2-methylfenyl)propan-1-on |
|
|
2-Methylmetamfetamin |
2-MMA |
1-(2-methylfenyl)-N-methylpropan-2-amin |
|
|
2-Methylmetkathinon |
2-MMC |
2-(methylamino)-1-(2-methylfenyl)propan-1-on |
|
|
2-Methyl-N,N-dimethylkathinon |
2-MDMC |
1-(2-methylfenyl)-2-(dimethylamino)propan-1-on |
|
|
2-Methyl-N-ethylnorpentedron |
2-MEAP |
2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on |
|
|
2-Methylthioamfetamin |
2-MTA |
(2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin |
|
|
2-Pyrrolidin-3-methoxy-propiofenon |
α-PPP-MeO; XXxXXX |
3-xxxxxxx-1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
3-(4-Xxxxxxxxxxxxxxxxxxxx)-1-xxxxxxxxxxx |
Xxx High |
[4-(hydroxymethyl)fenyl]-(1-pentyl-1H-indol-3-yl)methanon |
|
|
3-(p-Methoxybenzoyl)-N-methylindol |
(4-methoxyfenyl)(l -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
3',4'- Xxxxxxxxxxxxx-α-xxxxxx PPP |
MDMPP |
1-(3,4-methylendioxyfenyl)-2-methyl-2-pyrrolidinylpropan-1-on |
|
|
3,4-Dichlorethkathinon |
3,4-DCEC; |
1-(3,4-dichlorfenyl)-2-(ethylamino)propan-1-on |
|
|
3,4-Dichlormethylfenidát |
3,4-CTMP |
methyl (2X)-2-(3,4-xxxxxxxxxxxx)-2-[(2X)-xxxxxxxx-2-xx]xxxxxx |
|
|
3,4-Xxxxxxx-X,X-xxxxxxxxxxxxxxxxxxxx-xxxxxxxx |
3,4-XXXXXXX |
2-(xxxxxxxxxxxxxxxxxxxxx)-1-(3,4-xxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxx-α-XXX |
3,4-XXxX-α-XXX |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
3,4-XXxX-α-XXX |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
|
3',4'-Xxxxxxxxxxxxx-α-xxxxxxxxxxxxxxxx-xxxxx |
XXXXX |
(XX)-1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
|
3 ',4'-Xxxxxxxxxxxxx-α-XXX |
XXXXX |
1-(3,4-xxxxxxxxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
|
3 -Xxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-2-xxxxxxxxxxx-1-(3-xxxxxxxxxx)xxxxxx-1-xx |
|
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX; 3-xxxxxxxxxxxxxxxxxxxx |
X-xxxxx-1-(3-xxxxxxxxxx)xxxxxx-2-xxxx; X-xxxxx-3-xxxxxxxxxxxxxx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxx-α-XXX |
3X-α-XXX; 3X-XXX |
1-(3-xxxxxxxxxx)-2-(1-xxxxxxxxxx)xxxxxx-1-xx |
3-Xxxxx-α-XXX |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX, XXXX, 3-oxyfenazepam, 3 -xx droxy fenazepam |
7-brom-5-(2-chlorfenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
|
|
3-Hydroxyfencyklidin |
3-HO-PCP; |
3-[1-(piperidin-1-yl)cyklohexyl] xxxxx |
|
|
3-Xxxxxxxxxxxxxx |
3-XX |
1-(3-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-Xxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
3-Xxxxxxx xxxxxxxxxxx |
3-XxX-XXX |
X-xxxxx-1-(3-xxxxxxxxxxxx)xxxxxxxxxx-1-xxxx |
|
|
3-Xxxxxxx fencyklidin |
3-MeO-PCP |
1-[1-(3-methoxyfenyl)cyklohexyl]piperidin |
|
|
3-Methoxymethkathinon |
3-MeOMC |
1-(3-methoxyfenyl)-2-(methylamino)propan-1-on |
|
|
3-Methyl-4-fluormethkathinon |
3-Methylflefedron |
1-(4-fluor-3-methylfenyl)-2-(methylamino)propan-1-on |
|
|
3-Methylamfetamin |
3-MA |
(2RS)-1-(3-methylfenyl)propan-2-amin |
|
|
3-Methylethkathinon |
3-MEC |
2-(ethylamino)-1-(3-methylfenyl)propan-1-on |
|
|
3-Methylmetamfetamin |
3-MMA |
1-(3-methylfenyl)-N-methylpropan-2-amin |
|
|
3-Methylmetkathinon |
3-MMC |
2-(methylamino)-1-(3-methylfenyl)propan-1-on |
|
|
3-Methyl-N,N-dimethylkathinon |
3-MDMC |
1-(3-methylfenyl)-2-(dimethylamino)propan-1-on |
|
|
3-Methyl-N-ethylnorpentedron |
3-MEAP |
2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on |
|
|
3-Methylthioamfetamin |
3-MTA |
(2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin |
|
|
4'-Fluor-4-methylaminorex |
4-FPO; x-X-4-xxxxxxxxxxxxxx |
5-(4-xxxxxxxxxx)-4,5-xxxxxxx-4-xxxxxx-2-xxxxxxxxxx |
|
|
4'-Xxxxxx-X-xxxxxxxxxxxxxxxxxx |
4'-xxxxxx-XxXX |
1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XxXX |
4-xxxxxx-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-xxxxxx-α-XXX; XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4'-Xxxxx-α-XXX |
4'-xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
|
4-Xxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4Xx-α-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
|
4-Xxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4Xx-α-XXX; xXXXX, 4Xx-XXX |
1-(4-xxxxxxxxx)-2-xxxxxxxxxx-1-xx-xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-2-xxxxxxxxxxx-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4X-XXX; p-fluoroethylphenidate |
ethyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát |
|
|
4-Fluorkathinon |
4-FC |
2-amino-1-(4-fluorfenyl)-propan-1-on |
|
|
4-Fluormethamfetamin |
4-FMA |
(RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin |
|
|
4-Fluormethkathinon |
4-FMC |
1-(4-fluorfenyl)-2-(methylamino)propan-1-on |
Flefedron |
|
4F-MPH; 4-FMPH |
Methyl-2-(4-fluorfenyl)-2-(2-pipendyl)acetát |
4F-TMP |
|
|
4-Fluor-N-ethylbufedron |
4F-NEB |
2-(ethylamino)-1-(4-fluorfenyl)butan-1-on |
|
|
4-Fluor-N-ethylpentedron |
4F-NEP; 4-xxxxx-α-xxxxxxxxxx-xxxxxxxxxxx |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-X-xxxxxxxxxxxxxxxxxxxxx |
4X-XXX; 4F-NPP; 4X-XXXX |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XXX; 4-X-xxxxxxxxx |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxx-α-XXX; 4X-XXX; X-2370 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4X-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4X-α-XXX; 4X-XX8 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-X-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxxxx |
4X-xxxxx-XXxX; 4F-α-PiHP |
1-(4-fluorfenyl)-4-methyl-2-(pyrrolidin-1-yl)pentan-1-on |
|
|
4-Fluor-α-pyrrolidinoktanofenon |
4F-α-POP; 4X-XX9 |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4X-XXXX-XXXX |
xxxxxx (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
4X-XXXX-XXXXXX; 4F-ADB |
methyl (X)-2-({[1-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
4-X-α-XXX xxxxxxxxx analog |
1-(4-fluorfenyl)-2-(1-piperidyl)pentan-1-on |
||
|
4-HTMPIPO |
4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on |
||
|
4-Hydroxy-N-methyl-N-ethyl tryptamin |
4-HO-MET |
3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol |
Metocin; Xxxxxxxxxxx |
|
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-Xx-α-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
4-XX |
1-(4-xxxxxxxxxx)xxxxxx-2-xxxx |
XXX |
|
4-Xxxxxxxxxxxxx |
Xx5-4864, chlorodiazepam |
7-chlor-5-(4-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
|
|
4-Chlorethkathinon |
4-CEC |
1-(4-chlorfenyl)-2-(ethylamino)propan-1-on |
|
|
4-Chlorisopropylkathinon |
4-CIC; xxxxxxxxxxx, |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
x-XXX \ |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
|
4-Xxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXX; 4-XXXX |
1-(4-xxxxxxxxxx)-2-(X,X-xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-X-xxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxx)xxxxxx-1-xx |
4-Xxxxxxxxxxxxxxxxxx |
|
4-Xxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxx-α-XXX |
1-(4-xxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-XXXX |
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XXXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX; 4-XxX-α-XX8 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-xxxxxxx α-POP; 4-XxX-α-XX9 |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
4-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4-XxX-α-XXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
4'-Xxxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
4'-Xxxxxxx-α-XXX; XXXXX |
(XX)-1-(4-xxxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-XX |
|||
|
4-Xxxxxxxxxxxxxx |
4-Xx-XXXX |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxx |
Xxxxxxxxxxx; 4-XX |
2-xxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxx-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-xxxxxx-X-xxxxxxxxxxxxxx |
(4-XXX) |
(±)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
4'-Xxxxxx-α-xxxxxxxxxxxxxxxxxxxxx |
XXXX |
(XX)-1-(4-xxxxxxxxxxx)-2-(1-xxxxxxxxxxxx)xxxxx-1-xx |
|
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
|
5 - Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
|
5-XXXx; indanyl-α-PHP |
1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on |
||
|
5C-AKB48; 5X-XXXXXXX |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
5Xx-XX-XXXXXX |
X-[(2X)-1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx]-1-(5-xxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
5Xx-XXXX-XXXXXX; 5Cl-ADB |
methyl 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
|
5-Xx-xxxxxx XXX 018 indazol xxxxxx |
5Xx-XXX-018; 5Xx-XXX-018-X, THJ-018 xxxxxx xxxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
|
|
5 -Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
5X-3,5-XX-XXXXXXXX; 5F-3,5-AB-FUPPYCA, XX-037 |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
|
5X-5,3-XX-XXXXXXXX; 5X-XX-XXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-5-(4-xxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XX-X7XXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX48 |
X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXX57 |
xxxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XXX-XXXX |
xxxxxx (2S)-2-[[1-(5-fluorpentyl)indol-3-karbonyl]amino]-3-methylbutanoát |
||
|
5F-AMB-PINACA; 5F-AMB |
methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát |
5F-AMP |
|
|
5F-A-P7AICA |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid |
||
|
5F-APP-PICA |
N-(1-amino-1-oxo-3-fenylpropan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
|
5F-APP-PINACA |
N-(2-amino-1-benzyl-2-oxo-ethyl)-1-(5-fluorpentyl)indazol-3-karboxamid |
||
|
5F-CUMYL-PEGACLONE |
5-(5-fluorpentyl)-2-(1-methyl-1-fenylethyl)-pyrido[4,3-b]indol-1-on |
||
|
5F-EDMB-PINACA |
ethyl 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx |
||
|
5X-XXX-XXXXXX |
xxxxx 2-[[1-(5-fluorpentyl)indazol-3-karbonyl]amino]-3-methyl-butanoát |
||
|
5F-JWH-398; XX-2201; |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-xxxxxxxx |
||
|
5X-XXXX-X7XXXX |
xxxxxx-2-{[1-(5-xxxxxxxxxxx)-1X-xxxxxxx[2,3-x]xxxxxxx-3-xx]xxxxxxxxx}-3,3-xxxxxxxx xxxxxxxx |
||
|
5X-XXXX-XXXX; |
xxxxxx (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát |
||
|
5F-MDMB-PINACA; 5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
5X-XXXX-2 |
1-(5-xxxxxxxxxxx)-X-(xxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
5X-XX-22 indazol xxxxxx |
xxxxxxxx-8-xx 1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-fluorpentyl)-1H-indol-3-karboxylové |
||
|
5-F-pentyl-3-pyridinoylindol |
[1-(5-fluorpentyl)-1H-indol-3-yl] (pyridin-3-yl)methanon |
||
|
5F-PY-PICA |
1-(5-fluorpentyl)-3-(pyrrolidin-1-karbonyl)-1-H-indol |
||
|
5F-PY-PINACA |
[1-(5-fluorpentyl)indazol-3-yl]-pyrrolidin-1-yl-methanon |
||
|
5F-SDB-005 |
naftalen-1-yl-1-(5-fluorpentyl)-1H-indazol-3-karboxylát |
||
|
5F-SDB-006 |
N-benzyl-1-(5-fluorpentyl)-l X-xxxxx-3-xxxxxxxxxx |
||
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
|
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
5-XxX-XXX |
5 -xxxxxxx-α-xxxxxxxxxxxxxxx |
||
|
5-XxX-XXXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-(xxxx-2-xx-1-xx)xxxx-2-xx-1-xxxx |
||
|
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-xxxxxxx-X-xxxxxx-X-xxx-xxxxxx tryptamin |
||
|
5-Methoxymethy Ion |
N-methyl-bk-MMDA-5 |
1-(7-methoxybenzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
5-XXXx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
6-XXX |
6-(2-xxxxxxxxxxx)xxxxxxxxxx |
||
|
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
|
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
|
X-796,260 |
[1-(2-xxxxxxxx-4-xxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
X-796,260 xxxxxx |
((X)-1-(1-(2-xxxxxxx-1-xx)xxxxx)xxxxx-3-xx)-3,4,4-xxxxxxxxxxxx-2-xx-1-xx |
||
|
X-834,735 |
1-(xxxxxxxxxxxxxxx-4-xxxxxxxx)-1X-xxxxx-3-xx]-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
X-836,339 |
X-[3-(2-xxxxxxxxxxxx)-4,5-xxxxxxxx-1,3-xxxxxxx-2-xxxxxx]-2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx-xxxxxxxxxx |
||
|
XX-005 |
[1-[(1-xxxxxx-2-xxxxxxxxxxx)xxxxxx]-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)-xxxxxxxx |
||
|
XX-005 azepan xxxxxx |
(1-(1-xxxxxxxxxxxx-2-xx)-1X-xxxxx-3-xx)(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-[(2-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXXXX; |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-3-(4-xxxxxxxxxx)-1X-xxxxxxx-5-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-x(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXX |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorpentyl)-1H-indazol-3-karboxamid |
||
|
Adamantyl-THPINACA |
N-(1-adamantyl)-1-(tetrahy xxxxxxxx-4-xxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxx-xxxx |
||
|
XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-\X- xxxxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxxx |
X 41123 |
1-(8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,5-x][1,4]xxxxxxxxxxxxx-1-xx)-X,X-xxxxxxxxxxxxxx xxxx |
|
|
X-XXXXXXXX |
X-(1-xxxxxxxxx)-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-57 |
Xxxxxxx-1-xx-1-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
|
Xxxxxxxxxx xxxxxxxxxxxxxxxxx derivát |
(2-(3-(aminomethyl)-5-methyl-4-H-1,2,4-triazol-4-yl)-5-chlorfenyl)(fenyl)methanon |
||
|
AM-1220 |
1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl}(naftyl)-methanon |
||
|
AM-1220 xxxxxx xxxxxx |
1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx] (naftyl)methanon |
||
|
AM-1248 |
adamant-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanon |
||
|
AM-1248 xxxxxx xxxxxx |
xxxxxxx-1-xx(1-(1-xxxxxxxxxxxx-3-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XX-2201 xxxxxxxxxxxx xxxxxx; FUBIMINA |
(1-(5-fluorpentyl)-1H-benzo[d]imidazol-2-yl)(naftalen-1-yl)methanon |
||
|
AM-2201 xxxxxxx karboxamid analog |
N-1-naftalenyl-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
||
|
AM-2232 |
5-[3-(1-naftoyl)-1H-indol-1-yl]pentannitril |
||
|
AM-2233 |
1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodbenzoyl)indol |
||
|
AM-6527 |
1-pentyl-N-(naftalen-1-yl)-1H-indol-3-karboxamid |
||
|
AM-6527 5-xxxxxxxxxxx derivát |
1-(5-fluorpentyl)-N-(naftalen-1-yl)-1H-indol-3-kaboxamid |
||
|
AM-679 |
(2-iodfenyl)(1-pentyl-1H-indol-3-yl)methanon |
||
|
AM-694 |
1-[(5-fluorpentyl)-1H-indol-3-yl]-(2-iodfenyl)methanon |
||
|
AM-694 (xxxxx xxxxxxxxx iod) |
1-(5-fluorpentyl)-3-(2-ethylbenzoyl)indol |
||
|
AM-694 (xxxxxx xxxxxxxxx xxx) |
1-(5-xxxxxxxxxxx)-3-(2-xxxxxxxxxxxxx)xxxxx |
||
|
XX-694 xxxxx xxxxxxx |
1-[(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(2-xxxxxxxx)xxxxxxxx |
||
|
XXX-4xx-XXXX |
xxxxxx-3-xxxxxx-2-[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xxxxxxxxxxx]xxxxxxxx |
||
|
XXX-XXXXXX |
xxxxxx 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx]-3-xxxxxxxxxxxxxx |
||
|
XXX-XXXXXXXX; FUB-AMB |
Methyl 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
|
|
XXX-XXXXXX |
Xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
|
XXX-XXXxXXXX |
xxxxxx 2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx)-3-xxxxxxxxxxxxxx |
||
|
XXXXX; XXX-001, 2XX1 |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXXXX |
X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
XXX48 |
|
|
XXX-XXXXXX |
X-(1-xxxxx-1-xxx-3-xxxxxxxxxxx-2-xx)-1-xxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-XXXXXXXX |
X-(2-xxxxx-1-xxxxxx-2-xxx-xxxxx)-1-(xxxxxxxxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
xx-2X-X; βx-2X-X |
2-xxxxx-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxx-1-xx |
||
|
xx-XXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
||
|
xx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
||
|
xx-XXX |
2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx |
||
|
XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxx-1-xx |
||
|
XXXX; 3,4-XXXX |
2-xxxxxxxxxxx-1-(3,4-xxxxxxxxxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxx |
8-xxxx-6-xxxxx-1-xxxxxx-4X-xxxxx[x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
||
|
Xxxxx-Xxxxxxxxx |
(2X)-1-(4-xxxxxxxx[2,3-x][1]xxxxxxxxxx-8-xx)xxxxxx-2-xxxx |
||
|
Xxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxx-1-xx |
|
|
XXX-018 |
xxxxxxxx-1-xx 1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XX 47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxxx-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
|
XX 47,497 (X8 + X2) |
2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(2-xxxxxxxxxxx-2-xx)xxxxx; 2-((1X,3X)-3-xxxxxxxxxxxxxxxxx)-5-(xxxxx-3-xx)-xxxxx |
1,1-xxxxxxxx x 1-xxxxx derivát X8-xxxxxxxx |
|
|
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
|
XXXXX-4XX-X7XXXX |
1-(4-xxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-4XX-XXXXXX; XXX-78 |
1-(4-xxxxxxxxxx)-X-(1-xxxxxx-1-xxxxxxxxxx)xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-5X-X7XXXX |
1-(5-x:xxxφxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxx[2,3-x]xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-5XXXXX |
1-(5-xxxxxxxxxxx)-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXX-5XXXXXXX |
|||
|
XXXXX-XXXX |
1-xxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXX-XX-XXXXXXXXX |
5-(xxxxxxxxxxxxxxxx)-2-(1-xxxxxx-1-xxxxx-xxxxx)xxxxxx[4,3-x]xxxxx-1-xx |
||
|
XXXXX-XXXXXXXXX; XXX-151 |
2-(1-xxxxxx-1-xxxxxxxxxx)-5-xxxxxx-xxxxxx[4,3-x]xxxxx-1-xx |
||
|
XXXXX-XXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXXXX-XXXXXX |
1-xxxxxx-X-(2-xxxxxxxxxxx-2-xx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXXXX-XXXXXXXX |
X-(2-xxxxxxxxxxx-2-xx)-1-((xxxxxxxxxx-2X-xxxxx-4-xx)xxxxxx)-1-X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxx |
XXX-2; xxxxxxxx-2 |
2-xxxxx-9-xxxxxx-4-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
|
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx-X-xxxxx-xxxxxxx |
X-XXX; 2-Xxx-XXX, xxxxxxxxxxxx |
2-(xxxxxxxxxx)-2-xxxxxxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-1-xxxxxxx |
Xxxxxxxxxxxxx |
|
Xxxxxxxxxx |
2-xxxxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
Xx 5-3448 |
|
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx] xxxx |
|
|
Xxxxxxxxx |
XXX; 1,2-XXX; XXXX |
1-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
XX1X4X21 |
|
Xxxxxxxxxxxxx |
Xx 07-4065 |
7-xxxxx-5-(2,6-xxxxxxxxxxxx)-1-xxxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XX-4662 |
1-(3,4-xxxxxxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
|
Xxxxxxxxxx |
Xx-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
3,4-xxxxxxxxxxxxxxx- xxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxxx)-3΄,4΄-(xxxxxxxxxxxxx)xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxxxx)-xxxxxx-1-xx |
|
|
XXXX-XXXXXXXX |
2-(1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
XXX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]-(4-xxxxx-xxxxxxxx-1-xx)xxxxxxxx |
||
|
Xxxxxxxx |
XXXXX; ephenidine; EPE |
N-ethyl-1,2-difenylethylamin |
|
|
EG-018 |
naftalen-1-yl(9-pentyl-9H-karbazol-3-yl)methanon |
||
|
EG-2201 |
(9-(5-fluorpentyl)-9H-karbazol-3-yl)(naftalen-1-yl)methanon |
||
|
EMB-FUBINACA |
Ethyl 2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3-xxxxxx-xxxxxxxx |
||
|
Xxxxxxx |
XXXXX; bk-EBDP |
1-(benzo[d] [1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
|
Xxxxxxxxxxx |
Xxxxxxxxxxxx; X-xxxxxxxxxxxxxx; ETH-CAT |
2-ethylamino-1-fenyl-propan-1-on |
|
|
ETH-LAD |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindo1-[4,3-fg]chinolin-9-karboxamid |
||
|
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
|
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
|
Ethyltenamfetamin |
MDE, XXXX |
(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
|
Xxxxxxxx |
XXX3219; Xxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-9-xxxxxx-67/-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
|
Xxxxxxxxxx |
3-(2-xxxxxxxxxx)xxxxx |
||
|
Xxxxxxx |
xx-XXXX, X-Xxxxxxxxxxxxx |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
|
XXX-XX-22 |
1-xxxxxx 1-[(4-xxxxxxxxxx)xxxxxx]xxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxx |
xxxxxxxx |
4-xxxxx-3-xxxxxxxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxxxx |
Xx 11-5073/000 |
8-chlor-6-(2-fluorfenyl)-1-methyl -4X- [1,2,4]xxxxxxx[4,3-x] [1,4]benzodiazepin |
|
|
Flubromazepam |
7-brom-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Flubromazolam |
8-brom-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]tnazolo-[4,3a] [1,4]benzodiazepin |
||
|
Fluklotizolam |
2-chlor-4-(2-fluorfenyl)-9-methyl-6H-thieno[3,2-f] [1,2,4]xxxxxxx[4,3-x] [1,4] diazepin |
||
|
Flunitrazolam |
6-(2-fluorfenyl)-1-methyl-8-mtro-4H-[1,2,4]tnazolo[4,3-a] [1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
Xx 05-4435 |
5-(2-fluorfenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-on |
|
|
FUB-144 |
[1-[(4-fluorfenyl)methyl]indol-3-yl]-(2,2,3,3-tetramethylcyklopropyl)methanon |
||
|
FUB-AKB48 |
N-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid |
||
|
FUB-JWH-018 |
(1-(4-fluorbenzyl)-1H-indol-3-yl)(naftalen-1-yl)methanon |
||
|
FUB-NPB-22 |
chinolin-8-y1-(4-fluorbenzyl)-1H-indazol-3-karboxylát |
||
|
FUB-PB-22 |
chinolin-8-yl-1-(4-fluorbenzyl)-1H-indol-3-karboxylát |
||
| Hexahydrokanabiforol | HHCP | 6,6,9-trimethyl-3-heptyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol | |
| Hexahydrokanabihexol | HHCH; XXX-X6 | 6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx | |
| Xxxxxxxxxxxxxxxxxx | XXX | (6xX,10xX)-6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx | X xxxxxxxx látky HHC, xxxxx xx xxxxxxxx x xxxxxxxx technického xxxxxx, technickém konopí, xxxxxx xxxxxxx a xxxxxxxx x xxxxxxxxx x xxxxxxxxxxx xxxxxx x xxxxxxxx nižším xxx 0,3 %. Xxxx výjimka xx xxxxxxxxxx xx xxxxxxxxx. |
| Xxxxxxxxxxxxxxxxxx-X-xxxxxx | XXX-xxxxxx, XXX-X | [(6xX,10xX)-6,6,9-xxxxxxxxx-3-xxxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx] xxxxxx | |
| Xxxxxxxxxxxxxxxxxxxx | XXX-X8 | 6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx | |
| Xxxxxxxxxxxxxxxxxx | XXXX; XXX-X4 | 6,6,9-xxxxxxxxx-3-xxxxx-6x,7,8,9,10,10x-xxxxxxxxxxxxxx[x]xxxxxxx-1-xx | |
|
Xxxxxxxx |
β-xxxxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
|
Xxxxxxx |
βx-XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxx-1-xx |
|
|
XX-210 |
(6xX, 10xX)-9-(xxxxxxxxxxxxx)-6,6-xxxxxxxx-3-(2-xxxxxxxxxxx-2-xx)-6x,7,10,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx |
||
|
XX-331 |
3X,4X-x-xxxxxxxxxxx-3-xxxxxxx-2-x-xxxxxx-(1,8)-xxxx-3-xx-5-xxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxx |
(2X,X)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxx |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-xxxxx-2-(xxxxxxxxxx-1-xx)-xxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
|
Xxxxxxxxxxx |
4-xxxxxx-2-(xxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxxx |
XXXX |
xxxxxxxxx2-xxxxx-2-(2-xxxxxxxxx)xxxxxx |
|
|
XXX-907 |
X-(Xxxxx[1,3]xxxxxx-5-xxxxxxxx)-7-xxxxxxx-2-xxx-8-xxxxxxxxx-1,2-xxxxxxxxxxxxxxx-3-xxxxxxxxxx |
||
|
XXX 018 X-5-xxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX 018 X-5-xxxxxxxxxxx xxxxxxx |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-007 |
1-xxxxxx-2-xxxxxx-3-(1-xxxxxxx)xxxxx |
||
|
XXX-018 |
(xxxxxxxx-1-xx)(x -pentyl-1H-indol-3-yl)methanon |
||
|
JWH-018 adamantoyl xxxxxxx; |
1-xxxxxx-3-(xxxxxxx-1-xxx)xxxxx |
||
|
XXX-018 xxxxxxxxxxxxxxx derivát |
[1-(cyklohexylmethyl)-1H-indol-3-yl] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-018 |
chinolin-8-yl-1-pentyl-1H-indol-3-karboxylát |
||
|
JWH-018 xxxxxxx xxxxxx |
1-xxxxxxxxxx(1-xxxxxx-1X-xxxxxxx-3-xx)-xxxxxxxx |
||
|
XXX-019 |
1-xxxxx-3-(1-xxxxxxx)xxxxx |
||
|
XXX-022 |
xxxxxxxx-1-xx(2-(xxxx-4-xxxx)-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-030 |
xxxxxxxx-1-xx(1-xxxxxx-1X-xxxxxx-3-xx)xxxxxxxx |
||
|
XXX-071 |
(1-xxxxx-1X-xxxxx-3-xx)-1-xxxxxxxxx 1-xxxxxxxx |
||
|
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-073 xxxxxx xxxxxxx |
1-xxxxx-3-(1-(4-xxxxxx)xxxxxxx)xxxxx) |
||
|
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 xxxxxxxx 2-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxxx-1-xx)(2-xxxxxx 1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-122 xxxxxxxx derivát |
(4-methylnaftalen-1-yl)(1-(pent-4-en-1-yl)-1H-indol-3-yl)methanon |
||
|
JWH-145 |
naftalen-1-yl(1-pentyl-5-fenyl-1H-pyrrol-3-yl)methanon |
||
|
JWH-182 |
1-pentyl-3-(4-propyl-1-naftoyl)indol |
||
|
JWH-200 |
[1-(2-morfolinoethyl)-1H-indol-3-yl] (xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-203 |
2-(2-xxxxxxxxxx)-1-(1-xxxxxxxxxxx-3-xx)xxxxxxx |
||
|
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
|
XXX-2501 2-xxxxxxxx-X-xxxxxx-xxxxxxxxx xxxxxxx |
1-(2-xxxxxxxx-X-xxxxxxxxxxxxxxx)-3-(2-xxxxxxxxxxxxxxxxxx)xxxxx |
||
|
XXX-251 |
2-(2-xxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-302 |
1-xxxxxx-3-(3-xxxxxxxxxxxxxxxxxx)xxxxx |
||
|
XXX-307 |
(5-(2-xxxxxxxxxx)-1-xxxxxxxxxxxx-3-xx)-xxxxxxxx-1-xxxxxxxxxx |
||
|
XXX-307 xxxx xxxxxxx |
(5-(2-xxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
|
XXX-368 |
[5-(3-xxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
|
XXX-370 |
[5-(2-xxxxxxxxxxx)-1-xxxxxx-1X-xxxxxx-3-xx]-1-xxxxxxxxxx-xxxxxxxx |
||
|
XXX-387 |
1-xxxxxx-3-(4-xxxx-1-xxxxxxx)xxxxx |
||
|
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-412 |
|||
|
XXX-412 5-xxxxxxxxxxx xxxxxxx |
(4-xxxxxxxxxxxxx-1-xx)[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxx |
||
|
XXX-xxxxxxxxxxxxxxxx-8-xxxxxxxxxx; BB-22 |
chinolin-8-yl 1-(cyklohexylmethyl)-1H-indol-3-karboxylát |
||
|
Kathinon |
(2S)-2-amino-1-fenylpropan-1-on |
||
|
Klobromazolam |
phenazolam; XXX 4550445 |
8-brom-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]tnazolo[4,3-a] [1,4]benzodiazepin |
|
|
Klonazolam |
6-(2-chlorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin |
||
|
Kloniprazepam |
5-(2-chlorfenyl)-1-(cyklopropylmethyl)-7-mtro-1,3-dihydro-2H-[1,4]-benzodiazepin-2-on |
||
|
LTI-701 |
1-(5-fluorpentyl)-N-fenyl-indol-3-karboxamid |
||
|
LY2183240 |
N,N-dimethyl-5-[(4-bifenyl)methyl]tetrazol-1-karboxamid |
||
|
M5FPIC |
methyl-1-(5-fluorpentyl)-1H-indol-karboxylát |
||
|
MAM-2201 |
1-(5-fluorpentyl)-3-(4-methyl-naftoyl)indol |
||
|
MAM-2201 xxxxxxxxxxx derivát |
[1-(5-chlorpentyl)-1H-indol-3-yl](4-methyl-naftalen-1-yl)-methanon |
||
|
MBA-CHMINACA |
2-(1-(cyklohexylmethyl)-1H-indazol-3-karboxamido)-3-methylbutanová kyselina |
||
|
MBZP |
1 -xxxxxx-4-xxxxxxxxxxxxxxx |
||
|
XXX 19 |
X-[(X)-(1-xxxxx-2-xxxxxxxx-3-xxxxxx)xxxxx]xxxxxxxx |
||
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
|
XXXX-4xx-XXXXXX |
(xxxxxx 3,3-xxxxxxxx-2-(1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxxxxx) xxxxxxxx) |
||
|
XXXX-XXXXXX |
xxxxxx 2-(1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx)-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
|
XXXX-XXXXXXX |
xxxxxx 2-(9-(cyklohexylmethyl)-9H-karbazol-3-karboxamido)-3,3-dimethylbutanoát |
||
|
MDMB-CHMICA |
N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, xxxxxx ester |
||
|
MDMB-PCZCA |
methyl 3,3-xxxxxxxx-2-(9-xxxxxx-9 X-xxxxxxxx-3-xxxxxxxxxxx)xxxxxxxx |
||
|
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
|
Xxxxxxxxxxxx |
(X)-5-(2-xxxxxxxxxx)-3-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
(4-xxxxxxxxxxxxxxx-1-xx)-(1-xxxxxxxxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxx, Xxxxxxxxxxxxxxx |
2-xxxxxxxxxxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxxxx |
xxxxxxxxxxxxxxxxx, |
X-xxxxxx-1-(xxxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxx |
X-(2-xxxxxxx-xX-xxxxxxxxxxx)-5X,8X,11X,14X-xxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
xx-XXXX |
1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
|
xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
|
Xxxxxxxxxxxxxx |
XXXx, 2-Xxx-3'-xxxxxxx-XXXx |
2-(3-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxxx |
XX 690; XX-690; methylclonazepam; Xx 05-4082; Xx 5-4082 |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-3X-1,4-xxxxxxxxxxxxx-2-xx |
|
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
|
Xxxxxxxxxxxxxxxxxx |
XXXX |
(2X,X)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
|
Xxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
4-(2-xxxxxxxxxx)-2-xxxxx-6X-xxxxxx[3,2-x][1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxx |
|
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
|
X-XXXXX |
1-(xxxxxxxxxxxxxxxx)-2-xxxxxx-xxxxx-3-xxxxxxxxxx |
||
|
XX-18 |
X-(xxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XX-XXXXXXXX |
1-xxxxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx 1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXxX-2201 |
xxxxxx 2-{[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx]xxxxxxxxx}-3-xxxxxxxxxxxxxx |
||
|
X-(2-xxxxxxxxxxxx)-X-(1-xxxxxxxxxxx)-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
|
X,X-xxxxxxx-2-(1-xxxxxx-1X-xxxxx-3-xx)-4-xxxxxxx-xxxxxxxxxx |
|||
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
|
X-xxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxx, NBH |
2-(butylamino)-1-fenylhexan-1-on |
|
|
N-butylpentylon |
butyl-pentylone, xxxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxx, XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
|
XXX-xxxxx xxxxxx |
xx-XXX; , xx-XXXXX |
1-(2,3-xxxxxxx-1X-xxxxx-5-xx)-2-(xxxxxxxxxx)xxxxx-1-xx |
|
|
X-xxxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxx |
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxx)-1-xxxxx-xxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxx |
XXX-XX; Ethylhexedrone; Ethyl-Hex |
2-(ethylamino)-1-fenyl-hexan-1-on |
|
|
N-ethyl-isohexedron |
NEiH |
2-(ethylamino)-4-methyl-1-fenylpentan-1-on |
|
|
N-ethylnorpentedron |
N-ethylpentedron |
2-(ethylamino)-1-fenyl-pentan-1-on |
α-ethylaminopentiofe-non |
|
Nifoxipam |
5-(2-fluorfenyl)-3-hydroxy-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-on |
||
|
N-isopropylhexedron |
NiPH; X-xxxxxxxxxxxxxxxxx |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxx-1-xx |
|
|
X-xxxxxxxxxxxxxxxxxx |
XxXX; XXX, 2-XXX |
2-(xxxxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxx |
1-xxxxxx-8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxxx[4,3-x] [1,4]xxxxxxxxxxxxx |
||
|
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
|
X-xxxxxxxxxxxxxxx |
2-[xxxxxx(xxxxxx)xxxxx]-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxxxxx, desalkyl-flurazepam, xxxxxxxxxxxxx, Xx 5-3367 |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-2-xx |
|
|
X-xxxxxxxxxxxxxxxxxx |
X-xxxxxxxxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx }xxxxxx |
Xxxxxxxxxx |
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
|
Xxx 27569 |
5-xxxxx-3-xxxxx-X-{2-[4-(1-xxxxxxxxxxx)xxxxx]xxxxx}-1X-xxxxx-2-xxxxxxxxxx |
||
|
Xxx 27759 |
5-fluor-3-ethyl-N-{2-[4-(dimethylamino)fenyl]ethyl}-1H-indol-2-karboxamid |
||
|
Org 29647 |
5-xxxxx-3-xxxxx-X-(1-xxxxxxxxxxxxxxxx-3-xx)-3X-xxxxx-2-xxxxxxxxxx |
||
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
|
XX-22 xxxxxxx xxxxxx |
xxxxxxxx-8-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
||
|
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxxx; βx-XXXX |
(±)-1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
|
Xxxxxxxxxx |
XXX 48,098 |
(4-methoxyfenyl)-[2-methyl-1-(2-morfolin-4-ylethyl)indol-3-yl]methanon |
|
|
Propylkathinon |
N-propylcathinone; XX |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxx |
X-xxxxxxxxxxxxxxxxxx; |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
|
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
|
XX8, α-XXXX |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
XX9, α-XXX |
1 -xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
|
Xxxxxxxxx |
8-xxxx-1-xxxxxx-6-(xxxxxxx-2-xx)-4X-[1,2,4]xxxxxxxx[4,3 -a] [1,4]xxxxxxxxxxxxx |
||
|
XXX-4 |
(4-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-4 xxxxx xxxxxx |
(2-xxxxxxxxxxxx)(x -xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
XXX-4(X4) |
4-xxxxxxxxxxx1-(1-xxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX, PCPY |
1-(1-fenylcyklohexyl)pyrrolidin |
|
|
Salvinorin X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
||
|
XXX-005 |
xxxxxxxx-1-xx-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
|
XXX-006 |
X-xxxxxx-1-xxxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-006 X-xxxxx xxxxxx |
1-xxxxxx-X-xxxxx-1X-xxxxx-3-xxxxxxxxxx |
||
|
XXX-135 |
X-(1-xxxxxxxxx)-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
|
Xxxxxxxx |
xXxXXX; XXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxx-xxxxxxxxxx)xxxxxx-1-xx |
|
| Xxxxxxxxxxxxxxxxxxxxx | XXXX | (6xX,10xX)-3-xxxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx xxxxx-8-xxxxxxx. S xxxxxxxx xxxxx XXXX, xxxxx xx obsažena x xxxxxxxx xxxxxxxxxxx xxxxxx, technickém xxxxxx, xxxxxx extrakt x xxxxxxxx a xxxxxxxxx x technického konopí x množství nižším xxx 0,3 %. Xxxx výjimka xx xxxxxxxxxx na xxxxxxxxx. |
| Xxxxxxxxxxxxxxxxxxxxx | XXXX; XXX-X6 | (6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx xxxxx-8-xxxxxxx. S xxxxxxxx xxxxx XXXX, xxxxx xx obsažena x rostlině technického xxxxxx, xxxxxxxxxx xxxxxx, xxxxxx xxxxxxx x xxxxxxxx x xxxxxxxxx x xxxxxxxxxxx xxxxxx x xxxxxxxx nižším xxx 0,3 %. Xxxx xxxxxxx se xxxxxxxxxx na xxxxxxxxx. |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
Δ6x(10x)-, Δ6α(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly x xxxxxx stereoizomery |
|
| Tetrahydrokanabioktyl | THC-C8 | (6aR,10aR)-3-oktyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | Včetně xxxxx-8-xxxxxxx. |
| Xxxxxxxxxxxxxxxxxxx | XXXX; XXX-X4 | (6xX,10xX)-3-xxxxx-6,6,9-xxxxxxxxx-6x,7,8,10x-xxxxxxxxxxxxxxx[x]xxxxxxx-1-xx | Xxxxxx xxxxx-8-xxxxxxx. S xxxxxxxx xxxxx XXXX, xxxxx xx xxxxxxxx x rostlině technického xxxxxx, technickém konopí, xxxxxx xxxxxxx a xxxxxxxx a přípravku x xxxxxxxxxxx xxxxxx x xxxxxxxx nižším xxx 0,3 %. Xxxx xxxxxxx se xxxxxxxxxx xx xxxxxxxxx. |
|
Xxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xxxxx |
||
|
XXX-2201 |
5X-XXX-018-X, |
[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx] (1 -xxxxxx)xxxxxxxx |
|
|
XX-XXX; 3',4'-tetramethylene-α-PBP |
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronatalen-2-yl)butan-1-on |
||
|
TH-PHP; 2-xxxxxxxxx-1-xx-1-xxxxxxxx-6-xx- xxxxx-1-xx |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxx-1-xx |
||
|
XX-XXX |
2-(xxxxxxxxxx-1-xx)-1-(5,6,7,8-xxxxxxxxxxxxxxxxxx-2-xx)xxxxxx-1-xx |
||
|
xxxxx-XX 47,497-C8 |
5-(1,1-dimethyloktyl)-2-[(1S,3S)-3-hydroxycyklohexyl]-fenol |
||
|
Trimethoxyamfetamin |
TMA |
(2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin |
|
|
Trimethoxyamfetamin-2 |
TMA-2 |
(2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin |
|
|
UR-144(-2H); |
[1-(xxxx-4-xx-1-xx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
|
XX-144xxxxxx derivát |
(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)-methanon |
||
|
UR-144N-(5-chlorpentyl) derivát |
(1-(5-chlorpentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyklopropyl)methanon |
||
|
URB-597 |
[3-(3-karbamoylfenyl)fenyl]-N-cyklohexylkarbamát |
||
|
URB-754 |
6-methyl-2-[(4-methylfenyl)amino]-1-benzoxazin-4-on |
||
|
W-15 |
4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid |
||
|
W-18 |
4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid |
||
|
WIN 55212-2 |
(X)-(+)-[2,3-xxxxxxx-5-xxxxxx-3-(4-xxxxxxxxxxxxxxxx)xxxxxxx[1,2,3-xx]-1,4-xxxxxxxxxx-6-xxxxxxxxxxx-1-xxxxxxxxxx |
||
|
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
|
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
|
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-ΡιΗΡ |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxx |
α-XxxXX |
1-xxxxx-2-(xxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxx-1-xx |
|
|
α-Xxxxxxxxxxxxxxxxxxx |
α-XXX; XX-10; alpha-pyrrolidi-nononaphenone |
1-fenyl-2-(pyrrolidin-1-yl)nonan-1-on |
|
|
α-Pyrrolidinpropiofenon |
α-PPP |
1-fenyl-2-(pyrrolidin-1-yl)propan-1-on |
|
|
β-Keto-indanylmethylaminopropan |
bk-IMP |
1-(2,3-dihydro-1H-inden-5-yl)-2-(methylamino)propan-1-on |
Včetně xxxxxxxxxxxxx xxxxxxxxxxxxxx xxxxx, xx na xxxxxxxx xxxxxxx, uvedených x xxxxx xxxxxxx ve xxxxx xxxxxxxxx, xxx xxxx stereoizomery xxxxx xxxxxxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx, x xxxx a esterů xxxxxxxxxxxxxx xxxxx xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx xxxxx xxxxxxxxx..
Xxxxxxx x. 5 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 5 xxxxxxxxxxxxxx xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 7-[(10,11-xxxxxxx-5X-xxxxxxx[x,x][7]xxxxxxx-5-xx) amino]heptanová |
||
|
Buprenofin |
(2S)-2-[(5R,6R,7R,14S)-17-(cyklopropylmethyl)-4,5α-epoxy-3- xxxxxxx-6-xxxxxxx-6α,14-xxxxxxxxxxxxxx-7x-xx]-3,3-xxxxxxxx xxxxx-2-xx |
||
|
Xxxxxxxxxxxxxxxxxxxxx amin |
2C-B |
(4-brom-2,5-dimethoxyfenethyl)amin |
|
|
Dexamfetamin |
(2S)-1-fenylpropan-2-amin |
||
|
Fencyklidin |
PCP |
1-(1-fenylcyklohexyl)piperidin |
|
|
Fenetylin |
7-(2-{[(2RS)-1-fenylpropan-2-yl]amino}ethyl)-1,3-dimethyl-7H- xxxxx-2,6-xxxx |
||
|
Xxxxxxxxxxx |
2-xxxxX-3-xxxxxxxxxxxxxx |
||
| Xxxxxxxxx | 1-xxxxx-2-xxxxxxxxx-xxx-2-xxxx | ||
|
Xxxxxxxxxxxxx |
5-(2-xxxxxxxxxx)-1-xxxxxx-7-xxxxx-1X-1,4-xxxxxxxxxxxxx-2(3X)-xx |
||
|
XXX |
xxxxxxxx 4-xxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxxx |
(2XX)-1-xxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
| Xxxxxxxxxxxxxxx | (2X)-2,6-xxxxxxx-X-[(2X)-1-xxxxxxxxxxx-2-xx]xxxxxxxxx | ||
|
Xxxxxxxxxxx |
3-(2-xxxxxxxxxx)-2-xxxxxx-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxx |
2-xxxxxxx-3-(2-xxxxxxxxxxx)-1,2-xxxxxxxxxxxxxxxxx-4(3X)-xx |
||
|
Xxxxxxxxxxxx |
(2X)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxx xxxxxxxxx |
(2XX)-1-xxxxx-X-xxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxxxxxxx |
xxxxxx-(2XX)-2-xxxxx-2-[(2XX)-xxxxxxxxx-2-xx]xxxxxx |
||
|
Xxxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-(1-xxxxxxxxxxx)xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxx-9-XXX |
Δ9-xxxxxxxxxxxxxxxxxxx (XXX) x xxxx stereoizomery a xxxxxx |
xxxx. (-)-xxxxx-Δ9-XXX |
|
Xxxxxxxx |
(2XX)-1-xxxxx-1-xxxxxxx-3-[4-(2-xxxxxxxxxxxxxxx)xxxxxxxxx-1-xx] propan-2ol |
Včetně xxxx xxxxx xxxxxxxxx x xxxx xxxxxxx xx xxxxx případech, xxx existence takových xxxx xx xxxxx.
Xxxxxxx x. 6 x xxxxxxxx vlády x. 463/2013 Sb.
Seznam x. 6 psychotropních xxxxx
|
Xxxxxxxxxxx nechráněný xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx xxxx xxxxxx xxxxx |
Xxxxxxxx název xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxx |
xxxxxxxx 5-xxxxx-5-xxxxxxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
xxxxxxxx 5-allyl-5-isobutylbarbiturová |
||
|
Cyklobarbital |
kyselina 5-(1-xxxxxxxx-1-xx-1-xx)-5-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(3XX)-3-xxxxx-3-xxxxxxxxxxxxxx-2,6-xxxx |
||
|
Xxxxxx |
(+)-xxxxxxxxxxxxxxxx |
(1X,2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
|
|
Xxxxxxxxxxx |
(2X,6X,11X)-6,11-xxxxxxxx-3-(3-xxxxxxxxx-2-xx-1-xx)-1,2,3,4,5,6- hexahydro-2,6-methano-3-benzazocin-8-ol |
||
|
Pentobarbital |
kyselina 5-ethyl-5[(1RS)-1-methylbutyl]barbiturorá |
Včetně xxxx xxxxx xxxxxxxxx x této skupině xx všech xxxxxxxxx, xxx xxxxxxxxx xxxxxxxx xxxx xx xxxxx.
Xxxxxxx x. 7 x xxxxxxxx vlády x. 463/2013 Xx.
Xxxxxx x. 7 psychotropních xxxxx
|
Xxxxxxxxxxx xxxxxxxxxx xxxxx (XXX) x xxxxxx xxxxxx |
Xxxxx mezinárodní xxxxxxxxxx xxxxx nebo xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
|
Xxxxxxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
8-xxxxx-6-xxxxx-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-(xxxxxxxxxxxx)-1-xxxxxxxxxxx-1-xx |
||
|
Xxxxxxxx |
5-xxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
|
Xxxxxxxx |
5,5-xxxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxx |
XX 718; QM 6008; Xxxxxxxxxx; |
5-xxxxx-1,3,6,7,8,9-xxxxxxxxx-2X-[1]xxxxxxxxxxx[2,3-x] [1,4]diazepin-2-on |
|
|
Benzfetamin |
(+)-N-benzyl-N-(2-fenyl-1-methylethy)-N-methylamin |
||
|
Benzylpiperazin |
1-benzylpiperazin |
||
|
Bromazepam |
7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
||
|
Brotizolam |
2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin |
||
|
Butobarbital |
5-butyl-5-ethylbarbiturová xxxxxxxx |
||
|
Xxxxxxxxx |
XX-798; |
4-[[7-xxxx-5-(2-xxxxxxxxxx)-2-xxx-1,3-xxxxxxx-1,4-xxxxxxxxxxxxx-3-xx]xxx]-4-xxx-xxxxxxxx xxxxxxxx |
|
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
8-xxxxx-6-xxxxx-4X-[1,2,4]xxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
X-(1-xxxxxxxxxxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxxxxxxx |
1-xxxxx-3-xxxxxxxxx-1-xx-4-xx-3-xx |
||
|
Xxxxxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxx |
xxxxx-7-xxxxx-5-(2-xxxxxxxxxx)-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxx |
||
|
Xxxxxxxxx |
7-Xxxxx-5-(2-xxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxxx |
(2X,3X)-2-xxxxx-3,4-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
(±)-2-(xxxxxxxxxx)-3-xxxxxxxxxxxx[2.2.1]xxxxxx |
||
|
Xxxxxxxxxxxx |
5-xxxxx-5-xxxxxxxxxxxxxxxx kyselina |
||
|
Fenproporex |
(+)-1-fenyl-2-[(2-kyanethyl)amino] xxxxxx |
||
|
Xxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-2-[2-(xxxxxxxxxxxx)xxxxx]-5-(2-xxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XX-xxxxxx |
7-xxxxx-5-xxxxx-1-(2,2,2-xxxxxxxxxxxxx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
XX-xxxxxxxx |
10-xxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxxxxxxxx |
7-xxxxx-5-xxxxx-2-(xxxxxxxxxxx)-3X-1,4-xxxxxxxxxxxxx-4-xxxx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2-xxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-3-xx-xxxxxxxxxxxxxxxx |
||
|
Xxxxxxx |
(2XX)-2-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
11-xxxxx-12x-xxxxx-2,8-xxxxxxxx-8,12x-xxxxxxx-4X-[1,3]xxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-4,7(6X)-xxxx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-1X-1,5-xxxxxxxxxxxxx-2,4(3X,5X)-xxxx |
||
|
Xxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-2-xxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
5-(2-xxxxxxxxxx)-7-xxxxx-1-xxxxxx-1,3-xxxxxxx-2X-xxxxxx[2,3-x][1,4]xxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
10-xxxxx-11x-(2-xxxxxxxxxx)-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x][1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxxxx |
XXX |
(-)-1-(xxxxxxxxxxxxx)-1,2-xxxxxxxxxxxx |
|
|
Xxxxxxxxxx |
6-(2-xxxxxxxxxx)-2-[(4-xxxxxxxxxxxxxxx-1-xx)xxxxxx]-8-xxxxx-2,4-xxxxxxx-1X-xxxxxxx[1,2-x][1,4]xxxxxxxxxxxxx-1-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxxx |
7-xxxxx-5-(2-xxxxxxxxxx)-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
5-(4-xxxxxxxxxx)-2,5-xxxxxxx-3X-xxxxxxx[2.1-α]-xxxxxxxx-5-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-xxxxxx-2,3-xxxxxxx-1X-1,4-xxxxxxxxxxxxx |
||
|
Xxxxxxxxx |
(±)-2-[(3-xxxxxxxxxxx)xxxxx]-1-xxxxxxxxxxx |
||
|
Xxxxxxxxxx |
2-xxxxxx-2-xxxxxxxxxxxx-1,3-xxxx-xxxxxxxxxx |
||
|
Xxxxxxxx |
X-(xxxxxxxxxxxxxx)-3-(2-xxxxx-1-xxxxxxxxxxx)xxxxxxxxxx |
||
|
Xxxxxxxxxxxxxxxxxx |
5-xxxxx-5-xxxxx-1-xxxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxxxx |
3,3-xxxxxxx-5-xxxxxxxxxxxxxxx-2,4-xxxx |
||
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-xxxxxxx[1,5-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxxx |
5-xxxxx-1-xxxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
5-xxxxx-7-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
7-xxxxx-5-xxxxx-3-xxxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxx |
10-xxxxx-11x-xxxxx-2-xxxxxx-2,3,7,11x-xxxxxxxxxxxxxxxxx[3,2-x] [1,4]xxxxxxxxxxxxx-6(5X)-xx |
||
|
Xxxxxxx |
5-xxxxx-2-xxxxx-1,3-xxxxxxxxxx-4-xx |
||
|
Xxxxxxxxx |
7-xxxxx-5-xxxxx-1-(xxxx-2-xx-1-xx)-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxx |
xxxxxxx(2-xxxxxxxxx)xxxxxxxx |
||
|
Xxxxxxxx |
7-xxxxx-1-(xxxxxxxxxxxxxxxxx)-5-xxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxxx |
(+)-1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
||
|
Xxxxxxxxxxxxxxx |
5-xxxxx-5-(1-xxxxxxxxxxxx)xxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxxx |
(XX)-7-xxxxx-5-xxxxx-3-xxxxxxx-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
|
Xxxxxxxxxx |
7-xxxxx-5-(xxxxxxxx-1-xx-1-xx)-1-xxxxxx-1,3-xxxxxxx-2X-1,4-xxxxxxxxxxxxx-2-xx |
||
| Xxxxxxxxx | Xxxxxxxxx, Xxxxxxxxx, XXXX 341 Xxxxxxxxx, Xxxxxx, XX | 1-(3,4-xxxxxxxxxxxxxx)-5-xxxxx-7,8-xxxxxxxxx-4-xxxxxx-5X-2,3-xxxxxxxxxxxxx | |
|
Xxxxxxxxx |
8-xxxxx-6-(2-xxxxxxxxxx)-1-xxxxxx-4X-[1,2,4]xxxxxxxx[4,3-x][1,4]xxxxxxxxxxxxx |
||
|
Xxxxxxxxxx |
5-(1-xxxxxxxxxxx)-5-xxxxxxxxxxxxxxxx xxxxxxxx |
||
|
Xxxxxxxx |
X,X,6-xxxxxxxxx-2-(4-xxxxxxxxxxx)xxxxxxx[1,2-x]xxxxxxx-3-xxxxxxxx |
Xxxxxx xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx x&xxxx;xxxxx xxxxxxx xx xxxxx xxxxxxxxx, kdy xxxx xxxx mohou xxxxxxxxx.
Příloha x. 8 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 8 vybraných xxxxxxxxx
|
Xxxxxxxxx xxxxxxxxxx: |
Xxxxxxxx: |
||
|
1) |
xxxxx x xxxxxxxx xxxxx: xxxxxxxxxxxxxxxxxxx xxxxxxxxxxxxx xxxxXxxxxxx xxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx |
Xxxxx xxxxxxxxx xxxxx xxxx xxxx xxxxxxx látek (nikoliv xxxx omamných) a xxxxxxxx xxxxxx xxxxx |
|
|
x) |
x xxxxx xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx xxxxx nesmí xxxxxxxxxx 100 mg, |
||
|
b) |
v xxxxxxx xxxxx xxx koncentrace xxxxx xxx 2,5 % |
||
|
2) |
xxxxxxxxx |
x) |
Xxxxxxxx difenoxinu xxxxx xxxxxxxxxx v jedné xxxxxxx, tobolce, xxxxxx, xxxxx, xxxx. x xxxx xxxxxx xxxxx 0,5 mg. |
|
b) |
Množství xxxxxxx-xxxxxxx xxxx byt xxxxxxx 5 % x xxxxxxxx xxxxxxxxxxxx x xxxxx tabletě, xxxxxx, xxxxxx, čípku, xxxx. xxxx lékové xxxxx. |
||
|
3) |
xxxxxxxxxxx |
x) |
Xxxxxxxx xxxxxxxxxxxx xxxxx xxxxxxxxxx x jedné xxxxxxx, xxxxxxx, xxxxxx, čípku, xxxx. x xxxx xxxxxx xxxxx 2,5 xx. |
|
x) |
Xxxxxxxx xxxxxxx-xxxxxxx xxxx xxx xxxxxxx 1 % x xxxxxxxx xxxxxxxxxxxx x xxxxx xxxxxxx, xxxxxxx, ampuli, xxxxx, xxxx. x xxxx xxxxxx xxxxx. |
||
|
4) |
xxxxxxxxxxxxxxxx |
Xxxxxxxx xxxxxxxxxxxxxxxxx |
|
|
x) |
xxxxx přesáhnout 135 xx v xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, příp. x xxxx lékové xxxxx. |
||
|
x) |
x xxxxxxx xxxxx být xxxxxxxxxxx vyšší xxx 2,5 %. |
||
|
Xxxxxxxxx xxxxx xxxxxxxxx xxxxxx xxxxxxxxxxxx xxxxx. |
|||
|
5) |
xxxxxx |
Xxxxxxxx kokainu nesmí xxxxxxxxxx 0,1 % xxxxxxx. |
|
|
6) |
xxxxx xxxx xxxxxx |
x) |
Xxxxxxxx xxxxxxx nesmí xxxxxxxxxx 0,2 %. |
|
b) |
Dále xxxxx xxxxxxxxx jednu xxxx xxxx dalších látek (xxxxxxx však xxxxxxxx). |
||
|
Xxxxxx xxxxx x přípravku xxxxxxxx xxxxx být xxxxxx xxxxxxx zpět x takovém množství, xxx xxxxxxxx xxxxxxx xxxxxx |
|||
|
7) |
xxxxxxxxxxxxx prášek s xxxxx |
x) |
Xxxxxxxx xxxx x xxxxxx nesmí xxx xxxxx xxx 10 %. |
|
x) |
Xxxxxxxx xxxxxxxxxxxxxxx xxxxxx xxxxx být xxxxx xxx 10 %. |
||
|
c} |
Množství xxxxx xxxx xxxx xxxxxxx látek (xxxxxxx xxxx xxxxxxxxx) xxxxx xxx nižší xxx 80%. |
||
|
8) |
xxxxxxxxx |
x) |
Xxxxxxxxx xxxxxxxxx nesmí xxxxxxxxxx 100 mg x xxxxx xxxxxxx, xxxxxxx, xxxxxx, xxxxx, xxxx. x xxxx Xxxxxx xxxxx. |
|
x) |
Xxxxxxxxx xxxxxxxxxxxxxx x přípravku xxxx xxx xxxxxxx xxxxxx xxxx xxxxx xxx xxxxxxxxx. |
||
Xxxxxx homeopaticky xxxxxxxxxx xxxxxxxxx, xxxxxxx xxxxxx xxxxxx je xxxxx xxx X4 nebo XX2.
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx právním xxxxxxxxx x. 46/2017 Xx. x xxxxxxxxx od 1.3.2017
Čl. XX
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx směrnicí Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro služby xxxxxxxxxx xxxxxxxxxxx.
Xx. II xxxxxx xxxxxxx xxxxxxxxx x. 30/2018 Sb. x účinností od 8.3.2018
Čl. II
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx a Xxxx (EU) 2015/1535 xx xxx 9. xxxx 2015 o xxxxxxx xxx xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxx a xxxxxxxx pro služby xxxxxxxxxx společnosti.
Čl. II xxxxxx xxxxxxx xxxxxxxxx x. 242/2018 Xx. x účinností od 25.10.2018
Čl. XX
Xxxxxxxxx xxxxxxx
Xxxx xxxxxxxx xxxx xxxxxxxx x xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (EU) 2015/1535 xx xxx 9. září 2015 x xxxxxxx při xxxxxxxxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 184/2021 Xx. s xxxxxxxxx xx 3.6.2021
Xx. II
Technický předpis
Toto xxxxxxxx xxxx xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x postupu při xxxxxxxxxxx xxxxxxxxx x xxxxxxx technických předpisů x xxxxxxxx xxx xxxxxx informační xxxxxxxxxxx.
Xx. XX xxxxxx právním xxxxxxxxx x. 159/2022 Xx. s xxxxxxxxx xx 1.7.2022
Xx. XX
Xxxxxxxxx předpis
Toto xxxxxxxx xxxx xxxxxxxx x souladu xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2015/1535 xx xxx 9. xxxx 2015 x postupu xxx xxxxxxxxxxx xxxxxxxxx v xxxxxxx xxxxxxxxxxx předpisů x xxxxxxxx pro xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX xxxxxx xxxxxxx xxxxxxxxx x. 228/2023 Xx. s xxxxxxxxx xx 1.8.2023
Čl. II
Technický xxxxxxx
Xxxx xxxxxxxx bylo xxxxxxxx x xxxxxxx xx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (EU) 2015/1535 ze dne 9. xxxx 2015 x xxxxxxx xxx xxxxxxxxxxx informací x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Xx. XX vložen právním xxxxxxxxx č. 52/2024 Xx. s xxxxxxxxx xx 6.3.2024
Xx. II
Technický xxxxxxx
Xxxx xxxxxxxx xxxx oznámeno x xxxxxxx xx xxxxxxxx Xxxxxxxxxx parlamentu x Rady (XX) 2015/1535 xx xxx 9. září 2015 x postupu xxx xxxxxxxxxxx informací x xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx informační společnosti.
Čl. XX xxxxxx xxxxxxx xxxxxxxxx x. 176/2024 Xx. s účinností xx 1.7.2024
Xxxxxx xxxxxxx č. 463/2013 Sb. xxxxx xxxxxxxxx dnem 1.1.2014.
Xx xxxxx xxxxxx xxxxxxxx xxxxxxxx jsou xxxxxxxxxx xxxxx x doplnění xxxxxxxxxxx xxxxxxx předpisem x.:
243/2015 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek
s účinností xx 1.10.2015
46/2017 Sb., xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Sb., o xxxxxxxxx návykových xxxxx, xx znění xxxxxxxx xxxxx x. 243/2015 Xx.
x xxxxxxxxx od 1.3.2017 x xxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx účinnosti 1.5.2017
30/2018 Xx., xxxxxx xx xxxx nařízení xxxxx x. 463/2013 Sb., x seznamech xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 8.3.2018
242/2018 Xx., xxxxxx xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx od 25.10.2018
184/2021 Xx., kterým xx xxxx xxxxxxxx xxxxx x. 463/2013 Xx., x seznamech xxxxxxxxxx látek, xx xxxxx pozdějších xxxxxxxx
x xxxxxxxxx xx 3.6.2021
159/2022 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x účinností xx 1.7.2022
228/2023 Xx., xxxxxx se mění xxxxxxxx xxxxx x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.8.2023
52/2024 Xx., kterým xx xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 6.3.2024 x 1.1.2025
176/2023 Xx., xxxxxx se xxxx xxxxxxxx vlády x. 463/2013 Xx., o xxxxxxxxx xxxxxxxxxx xxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.7.2024 a 1.1.2025
419/2024 Xx., kterým se xxxx nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx
x xxxxxxxxx xx 1.1.2025 x 1.4.2025
Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx netýká xxxxxxxxx změna xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.
1) Xxxxxxxx úmluva x xxxxxxxx xxxxxxx, xxxxxxxxx pod č. 47/1965 Sb., xx znění Xxxxxxxxx x xxxxxxx Xxxxxxxx xxxxxx x xxxxxxxx xxxxxxx, xxxxxxxxxxx xxx č. 458/1991 Sb.
Xxxxxxxx Komise v xxxxxxxxx pravomoci (XX) 2022/1326 xx dne 18. xxxxxx 2022, xxxxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx o xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxx xx xxxxxxxx xxxxx.
2) Xxxxxx x xxxxxxxxxxxxxx látkách, xxxxxxxxx xxx č. 62/1989 Sb.
3) Xxxxxxx xxxxxxxxxx Xxxx 2004/757/XXX ze xxx 25. xxxxx 2004, xxxxxx xx xxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx se xxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx xxxx x sankcí x oblasti xxxxxxxxxxxx xxxxxxx s drogami.
Směrnice Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) 2017/2103 xx xxx 15. xxxxxxxxx 2017, kterou xx xxxx xxxxxxx xxxxxxxxxx Rady 2004/757/XXX x xxxxx xxxxxxxx xx definice xxxxx xxxx xxxxxxxxxxxxx xxxxx x zrušuje xxxxxxxxxx Xxxx 2005/387/XXX.
Xxxxxxxx Xxxxxx x přenesené xxxxxxxxx (XX) 2019/369 ze xxx 13. prosince 2018, kterou xx xxxx xxxxxxx xxxxxxxxx xxxxxxxxxx Rady 2004/757/XXX, xxxxx xxx x xxxxxxxx nových psychoaktivních xxxxx do xxxxxxxx xxxxx.
Xxxxxxxx Xxxxxx v xxxxxxxxx xxxxxxxxx (XX) 2020/1687 xx dne 2. září 2020, xxxxxx xx mění xxxxxxx rámcového xxxxxxxxxx Xxxx 2004/757/XXX, xxxxx xxx o zahrnutí xxxx psychoaktivní látky X,X-xxxxxxx-2-[[4-(1-xxxxxxxxxxxx)xxxxx]xxxxxx]-5-xxxxx-1 H-benzimidazol-1-ethanamin (xxxxxxxxxxxx) xx definice drogy.
Směrnice Xxxxxx x xxxxxxxxx xxxxxxxxx (EU) 2021/802 xx xxx 12. xxxxxx 2021, kterou xx mění xxxxxxx xxxxxxxxx xxxxxxxxxx Rady 2004/757/XXX, pokud xxx x xxxxxxxx xxxxxx xxxxxxxxxxxxxxx xxxxx xxxxxx 3,3-xxxxxxxx-2-{[1-(xxxx-4-xx-1-xx)-1X-xxxxxxx-3-xxxxxxxx]xxxxx} xxxxxxxx (XXXX-4xx-XXXXXX) x xxxxxx 2-{[1-(4-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxx]xxxxx}-3,3-xxxxxxxxxxxxxxxx (4X-XXXX-XXXX) xx definice xxxxx.